Neurodynamic Mobilization for the Management of Patients With Lumbar Disc Herniation: A Randomized Controlled Study
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 40
- Locations
- 2
- Primary Endpoint
- Pain Intensity
Study Overview
Brief Summary
The objective of this randomized controlled trial was to investigate the effects of neurodynamic mobilization on pain intensity, normal joint motion, neurodynamics, functional level, and disability in patients with lumbar disc herniation.
Detailed Description
Background: Low back pain is a major cause of disability worldwide, and due to the limited effectiveness of current treatments, this study aimed to evaluate the efficacy of neurodynamic mobilization technique on pain intensity, range of motion, neurodynamics, functional status, and disability in patients.
Methods: Thirty-seven patients were randomized to control or mobilization group. Participants in the control group received a conventional therapy for 20 treatment sessions, and those in the mobilization group were treated neurodynamic mobilization in addition to the electro/thermal therapy program twice a week for 4 consecutive weeks. Pain level at rest and during activity was recorded with a Visual Analog Scale. Active lumbar flexion, extension, and lateral flexion were measured with a universal goniometer. Neurodynamic mobility was evaluated using neurodynamic tests. The functional status was assessed with the 30-second chair stand test and disability was evaluated with the Bournemouth Questionnaire. 2x2 repeated measures ANOVA models were used to determine within and between group differences.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 20 Years to 60 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Age between 20 and 60 years
- •Diagnosed with lumbar disc herniation at one or more of the L3-L4, L4-L5
- •L5-S1 levels with prolapsed, protruding, or extruding disc confirmed by MRI
- •Presence of low back pain for at least 6 weeks.
Exclusion Criteria
- •Spinal stenosis
- •Previous lumbar surgery or medical treatment for disc herniation
- •Pregnancy
- •Severe osteoporosis
- •Diabetes mellitus
- •Severe neurological deficit
Outcomes
Primary Outcomes
Pain Intensity
Time Frame: Pain was assessed at baseline (before treatment) and at the end of 4 weeks of treatment (post-treatment)
Patients' rest and activity pain levels was assessed via a visual analog scale (VAS). Participants were asked to mark the intensity of pain they felt on a 10-centimeter (cm) horizontal line (0 indicates no pain, 10 indicates intolerable pain). The point marked on the line was measured with a ruler and the VAS value was recorded in cm
Pain Intensity
Time Frame: Pain was assessed at baseline (before treatment) and at the end of 4 weeks of treatment (post-treatment)
Patients' rest and activity pain levels was assessed via a visual analog scale (VAS). Participants were asked to mark the intensity of pain they felt on a 10-centimeter (cm) horizontal line (0 indicates no pain, 10 indicates intolerable pain). The point marked on the line was measured with a ruler and the VAS value was recorded in cm
Secondary Outcomes
- ROM(Rom was assessed at baseline (before treatment) and at the end of 4 weeks of treatment (post-treatment).)
- Neurodynamic Mobility - Slump Test(These were assessed at baseline (before treatment) and at the end of 4 weeks of treatment (post-treatment).)
- Neurodynamic Mobility - Sit and Reach Test(Baseline (before treatment) and at the end of 4 weeks of treatment (post-treatment))
- ROM(Rom was assessed at baseline (before treatment) and at the end of 4 weeks of treatment (post-treatment).)
- Neurodynamic Mobility - Slump Test(These were assessed at baseline (before treatment) and at the end of 4 weeks of treatment (post-treatment).)
- Neurodynamic Mobility - Sit and Reach Test(Baseline (before treatment) and at the end of 4 weeks of treatment (post-treatment))
Investigators
Gurkan Gunaydin
Associate Professor
Aydin Adnan Menderes University